This site is no longer being updated. Data are accurate as of 2 Dec 2022.

Chumakov Center: KoviVac

Chumakov Center: KoviVac

Vaccine Type: Inactivated

About Trial Phases

Phase 1: 2 Trials

502
Russian Federation
NCT05046548
Russian Federation

Phase 2: 3 Trials

502
Russian Federation
622
Russian Federation
NCT05046548
Russian Federation

Phase 3: 0 Trials

There are no trials for this phase.

Approvals

3 Countries

Registered Trials

622
Phase 2
Russian Federation
Total Enrollment: 250
Official Trial Registration:
- 622(Opens in new tab/window)
502
Phase 1/2
Russian Federation
Total Enrollment: 600
Official Trial Registration:
- 502(Opens in new tab/window)
NCT05046548
Phase 1/2
Russian Federation
Total Enrollment: 400
Official Trial Registration:
- NCT05046548(Opens in new tab/window)

© 2023 VIPER Group COVID19 Vaccine Tracker Team

Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)

This site is provided for informational purposes only based on publically available data.

Site Credits Website Feedback Form